QCG
ARRY

Quadrant Capital Group’s Array Biopharma Inc ARRY Stock Holding History

Quadrant Capital Group’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,040
Closed -$48K – 2464
2019
Q2 		$48K Buy
+1,040
New +$29.2K 0.01% 1241

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Quadrant Capital Group's ARRY Position: Q3 2019 in Review

Quadrant Capital Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,040 shares — an estimated $48K sold.

Quadrant Capital Group first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $48K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Quadrant Capital Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Quadrant Capital Group sold 1,040 Array Biopharma Inc shares in Q3 2019, an estimated $48K.
  • Quadrant Capital Group first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Quadrant Capital Group's Array Biopharma Inc position peaked at $48K in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Quadrant Capital Group's 13F filing for Q3 2019, filed 24 Oct 2019.